loadpatents
name:-0.024805068969727
name:-0.28617191314697
name:-0.0019540786743164
ZAMPONI; Gerald W. Patent Filings

ZAMPONI; Gerald W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZAMPONI; Gerald W..The latest application filed is for "use of t-type calcium channel blocker for treating pruritus".

Company Profile
1.7.12
  • ZAMPONI; Gerald W. - Calgary CA
  • Zamponi; Gerald W. - Cochrane CA
  • Zamponi; Gerald W. - Calagary CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use Of T-type Calcium Channel Blocker For Treating Pruritus
App 20220226299 - ZAMPONI; Gerald W. ;   et al.
2022-07-21
Products And Methods Associated With Multiple Sclerosis As A Transmissible Protein Misfolding Disorder
App 20200229407 - Stys; Peter ;   et al.
2020-07-23
Treatment of pain by inhibition of USP5 de-ubiquitinase
Grant 9,993,522 - Garcia-Caballero , et al. June 12, 2
2018-06-12
Treatment Of Pain By Inhibition Of Usp5 De-ubiquitinase
App 20150231203 - Garcia-Caballero; Agustin ;   et al.
2015-08-20
Calcium channel blockers
Grant 7,666,865 - Snutch , et al. February 23, 2
2010-02-23
Calcium channel blockers
App 20070185105 - Snutch; Terrance P. ;   et al.
2007-08-09
Preferentially substituted calcium channel blockers
Grant 7,186,726 - Snutch , et al. March 6, 2
2007-03-06
Preferentially substituted calcium channel blockers
Grant 7,064,128 - Snutch , et al. June 20, 2
2006-06-20
Calcium channel blockers comprising two benzhydril moieties
App 20060084660 - Snutch; Terrance P. ;   et al.
2006-04-20
Calcium channel blockers comprising two benzhydril moieties
Grant 6,951,862 - Snutch , et al. October 4, 2
2005-10-04
Calcium channel blockers comprising two benzhydril moieties
Grant 6,949,554 - Snutch , et al. September 27, 2
2005-09-27
Calcium channel inhibitors comprising benzhydril spaced from piperazine
Grant 6,943,168 - Snutch , et al. September 13, 2
2005-09-13
Calcium channel inhibitors comprising benzhydril spaced from piperazine
App 20040266784 - Snutch, Terrance P. ;   et al.
2004-12-30
Calcium channel blockers comprising two benzhydril moieties
App 20040259866 - Snutch, Terrance P. ;   et al.
2004-12-23
Calcium channel blockers comprising two benzhydril moieties
App 20040209872 - Snutch, Terrance P. ;   et al.
2004-10-21
Preferentially substituted calcium channel blockers
App 20040192703 - Snutch, Terrance P. ;   et al.
2004-09-30
Preferentially substituted calcium channel blockers
App 20040147529 - Snutch, Terrance P. ;   et al.
2004-07-29
Calcium channel inhibitors comprising benzhydril spaced from piperazine
App 20040044004 - Snutch, Terrance P. ;   et al.
2004-03-04
Calcium channel inhibitors comprising benzhydril spaced from piperazine
App 20040034035 - Snutch, Terrance P. ;   et al.
2004-02-19
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed